-
Janssen Biotech, Inc. et al v. Celltrion Healthcare Co., Ltd. et al DC CAFC
- 1:15-cv-10698
- D. Mass.
- Judge: Mark L. Wolf
- Filed: 03/06/2015
- Closed: 03/15/2018
- Latest Docket Entry: 01/24/2020
- PACER
- Docket updated daily
2
Plaintiffs
3
Defendants
1
Accused
Product
6
Patents-in-Suit
1,106
Days in
Litigation
-
Janssen Biotech, Inc. et al v. Celltrion Healthcare Co., Ltd. et al DC CAFC
- 1:15-cv-10698
- D. Mass.
- Judge: Mark L. Wolf
- Filed: 03/06/2015
- Closed: 03/15/2018
- Latest Docket Entry: 01/24/2020
- PACER
- Docket updated daily
Cause of Action
Infringement
Market Sector
Biotech and Pharma
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
Claim # | Claim Text | Outcome |
---|---|---|
1 |
A chimeric antibody comprising at least part of a human immunoglobulin constant region and at least part of a non-human immunoglobulin variable region, said antibody capable of binding an epitope specific for human tumor necrosis factor TNFα, wherein
view more
|
Invalid (101 and 103)
Entry 255 |
3 |
A chimeric antibody comprising at least part of a human immunoglobulin constant region and at least part of a non-human immunoglobulin variable region, said antibody capable of binding an epitope specific for human tumor necrosis factor TNFα, wherein
view more
|
Invalid (101 and 103)
Entry 255 |
5 |
A chimeric antibody, comprising two light chains and two heavy chains, each of said chains comprising at least part of a human immunoglobulin constant region and at least part of a non-human immunoglobulin variable region, said variable region
view more
|
Invalid (101 and 103)
Entry 255 |
6 |
A chimeric antibody according to claim <HIL><BOLD>5</BOLD></HIL>, wherein the human immunoglobulin constant region is an IgG1.
|
Invalid (101 and 103)
Entry 255 |
7 |
A chimeric antibody comprising at least part of a human IgG1 constant region and at least part of a non-human immunoglobulin variable region, said antibody capable of binding an epitope specific for human TNFα, wherein the non-human immunoglobulin
view more
|
Invalid (101 and 103)
Entry 255 |